City

Hangzhou (1)

Shanghai (1)

Condition

Metastatic Breast Cancer in the Liver (2)

Overall Status

Recruiting (2)

Sign in for free

Phase

phase 2 (1)

Sponsor

Fudan University (1)

Zhejiang Cancer Hospital (1)

Collaborator

Intervention

chemotherapy (1)

cryoablation combined with tirelizumab and bevacizumab (1)

Study Documents

Intervention Type

combination product (1)

drug (1)

Funder Type

Other (2)

Study Type

Interventional (1)

Observational (1)

metastatic breast cancer in the liver

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Dynamic Contrast-enhanced MRI Combined With IVIM-DWI for Early

Recruiting

Metastatic Breast Cancer in the Liver

Chemotherapy

Hangzhou, Zhejiang, China

Zhejiang Cancer Hospital

Sep 23, 2022

Metastatic Breast Cancer in the Liver Trial in Shanghai (Cryoablation Combined with Tirelizumab and Bevacizumab)

Recruiting

Metastatic Breast Cancer in the Liver

Cryoablation Combined with Tirelizumab and Bevacizumab

Shanghai, Shanghai, China
+1 more

Jun 6, 2022